Transformational leader known for driving end-to-end innovation across global drug development, access strategy, and medical affairs—delivering measurable value through cross-functional execution and an industry-shaping vision. Brings a distinctive ability to synthesize scientific, regulatory, and commercial complexity into clear, actionable strategy that accelerates innovation, expands access, and positions assets for sustained impact. Adept at steering matrixed, enterprise-scale initiatives through ambiguity and scale, aligning global and U.S. stakeholders around common goals to drive patient-centered outcomes and business performance. Recognized for mobilizing high-performing teams, building trust in complex stakeholder ecosystems, and executing with precision across therapeutic areas and stages of development. Equally committed to performance and purpose, with a leadership philosophy grounded in inclusion, integrity, and advancing meaningful innovation in healthcare.

CORE COMPETENCIES:

·       Program Execution & Oversight

·       Risk & Issue Management

·       Global Asset Strategy

·       Regulatory & Commercial Readiness

·       Asset Lifecycle Management 

·       Cross-Functional Leadership